Flossing Band Integration in Conventional Physiotherapy for Patellofemoral Pain Syndrome (flossing)

February 22, 2024 updated by: DAVID CRUZ DÍAZ, University of Jaén

Evaluating the Impact of Flossing Band Integration in Conventional Physiotherapy for Patellofemoral Pain Syndrome

The goal of this clinical trial is to assess the efficacy of adding flossing band therapy to conventional physiotherapy in patients diagnosed with Patellofemoral Pain Syndrome (PFPS). The main questions it aims to answer are:

  • Does combining flossing band therapy with conventional physiotherapy lead to greater improvements in pain, strength, and function compared to conventional physiotherapy alone?
  • What are the effects of flossing band therapy on knee functionality and muscle strength in PFPS patients? Participants will be randomly assigned to either the Standard Physiotherapy group or the Flossing Band and Physiotherapy group. In addition to conventional physiotherapy, participants in the Flossing Band group will undergo sessions where a flossing band is applied around the knee joint to provide moderate compression. Researchers will compare the two groups to determine if the addition of flossing band therapy enhances treatment outcomes for PFPS.

Study Overview

Detailed Description

The goal of this clinical trial is to assess the efficacy of integrating flossing band therapy into conventional physiotherapy for individuals diagnosed with Patellofemoral Pain Syndrome (PFPS). A double-blinded, randomized controlled trial was conducted to evaluate the influence of adding flossing band application to conventional physiotherapy based on 8 weeks of resistance training in patients with PFPS. The study was approved by the research ethics committee of the University of Jaén and conducted in accordance with the Code of Ethics of the World Medical Association for human studies (Declaration of Helsinki). A sample of 50 participants diagnosed with PFPS were randomly allocated into two distinct groups: the Standard Physiotherapy Group (SPG) and the Flossing Band and Physiotherapy Group (FBPG). Eligibility criteria included a clinical diagnosis of PFPS, retro patellar pain for at least three months, and no recent medical treatment or lower extremity surgery within the last six months. Participants underwent assessments at baseline and after 8 weeks of rehabilitation protocols, including standardized measures of pain intensity, knee functionality, and overall mobility. The intervention protocols involved either conventional physiotherapy focused on neuromuscular training or a combined treatment regimen of conventional physiotherapy along with additional flossing band therapy targeting the knee region. Researchers applied rigorous blinding protocols to ensure impartial evaluations and minimize bias. Outcome measures included the Kujala Anterior Knee Pain Scale (AKPS), handheld dynamometry for knee extensor muscle strength, a visual analog scale (VAS) for pain assessment, and the Lower Extremity Functional Scale (LEFS) for self-reported function, isokinetic variables, including peak torque, total work, and average power, were assessed using the Biodex System 4 dynamometer and emotional and psychological variables. The study aimed to determine if the addition of flossing band therapy enhances treatment outcomes for PFPS compared to conventional physiotherapy alone.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jaen, Spain, 23009
        • University of Jaén

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • A clinical diagnosis of Patellofemoral Pain Syndrome or patellofemoral misalignment, as confirmed by clinical signs and/or imaging studies (e.g., knee CT scans).
  • An age range of 18 to 50 years, to include a broad spectrum of the population affected by PFPS.
  • Experience retro patellar pain for at least three months, including pain at rest or during activities such as ascending or descending stairs, jumping, running, squatting, kneeling, or prolonged sitting.
  • Pain or apprehension upon mobilization of the patella, and/or crepitus accompanied by pain during activities like squats.
  • No history of medical treatment, physiotherapy specifically targeting PFPS, or lower extremity surgery within the last six months.

Exclusion Criteria:

  • A history of significant lower extremity, pelvic, or spinal surgery/fracture, or traumatic lesions of ligaments or meniscus within the past six months.

    • Presence of other orthopedic conditions (e.g., ligament rupture, meniscal tears), neurological disorders (e.g., multiple sclerosis, paralysis), rheumatological diseases (e.g., rheumatoid arthritis, ankylosing spondylitis), or congenital conditions leading to osteoarthrosis.
    • Current pregnancy.
    • A history of connective tissue disease, patellofemoral dislocation or subluxation, or osteoarthrosis of the knees.
    • Use of sedatives or muscle relaxants that may alter muscle tone.
    • Other forms of anterior knee pain (e.g., Osgood-Schlatter disease, tendon pain, bursitis).
    • A history of referred pain from the lumbar spine.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group

The intervention protocol is centered on neuromuscular training, targeting the strengthening of key muscle groups including the quadriceps, hamstrings, and hip abductors, which are vital for knee stabilization. This approach is supported by previous research, emphasizing the importance of these muscle groups in knee joint health. Complementing this, proprioceptive exercises, such as single-leg balances and controlled knee bends, were incorporated to enhance joint position sense, aligning with the guidelines set forth by Powers et al., 2010.

The intensity of these exercises is progressively increased, tailored to each patient's tolerance and improvement. The protocol stipulates two sessions per week over eight weeks.

The intervention protocol is centered on neuromuscular training, targeting the strengthening of key muscle groups including the quadriceps, hamstrings, and hip abductors, which are vital for knee stabilization. This approach is supported by previous research, emphasizing the importance of these muscle groups in knee joint health. Complementing this, proprioceptive exercises, such as single-leg balances and controlled knee bends, were incorporated to enhance joint position sense, aligning with the guidelines set forth by Powers et al., 2010.

The intensity of these exercises is progressively increased, tailored to each patient's tolerance and improvement. The protocol stipulates two sessions per week over eight weeks.

Experimental: Intervention group
The application of flossing to the knee commences with a preliminary evaluation of the joint range of motion and pain perception. The band is wrapped around the knee, starting with an approximate tension of 50% for the first wrap and escalating to a tension of 60-80% in subsequent wraps. It is essential to overlap the band with each wrap, moving from a distal to the proximal direction (bottom to top), which aids in enhancing drainage. Continuous monitoring of the patient is critical to ensure that excessive pressure is not being applied. This can be achieved by palpating the pulse on the dorsum of the foot or inner ankle, and observing if the skin regains its normal color after pressing the area with fingers. Should the patient experience strong tingling or pain, the bandage must be immediately removed. The duration of the band's application varies between 2 to 5 minutes, depending on patient tolerance, a methodology informed by existing research.
The application of flossing to the knee commences with a preliminary evaluation of the joint range of motion and pain perception. The band is wrapped around the knee, starting with an approximate tension of 50% for the first wrap and escalating to a tension of 60-80% in subsequent wraps. It's essential to overlap the band with each wrap, moving from a distal to the proximal direction (bottom to top), which aids in enhancing drainage. Continuous monitoring of the patient is critical to ensure that excessive pressure is not being applied. This can be achieved by palpating the pulse on the dorsum of the foot or inner ankle, and observing if the skin regains its normal color after pressing the area with fingers. Should the patient experience strong tingling or pain, the bandage must be immediately removed. The duration of the band's application varies between 2 to 5 minutes, depending on patient tolerance, a methodology informed by existing research.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disability related to patellofemoral pain
Time Frame: From baseline to 8 weeks
The Kujala Anterior Knee Pain Scale was employed to assess this variable. is a well-established tool used to evaluate symptoms and functional limitations in individuals with patellofemoral pain syndrome. This self-reported questionnaire comprises 13 items, each rated to provide a total score ranging from 0 to 100, where higher scores denote better knee function and fewer symptoms. While specific cut-off points are not universally defined, scores closer to 100 generally indicate minimal patellofemoral issues.
From baseline to 8 weeks
Knee extensor muscle strength
Time Frame: From baseline to 8 weeks
In addition to isokinetic variables assessed with the Biodex System 4 dynamometer, manual handheld dynamometry was employed to measure knee extensor muscle strength, providing a comprehensive evaluation of muscle function in individuals with Patellofemoral Pain Syndrome.
From baseline to 8 weeks
Pain report
Time Frame: From baseline to 8 weeks
Pain was measured using a visual analogue scale (VAS). The VAS consists of a 10-cm line, with the left extremity representing (the absence of pain) and the right extremity indicating (the worse pain devisable). Participants were asked to indicate on the scale their current level of pain being higher values related to more intense pain.
From baseline to 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported function
Time Frame: From baseline to 8 weeks
Self-reported function: The lower limb function was assessed by the Lower Extremity Functional Scale (LEFS) is a valid and reliable instrument to determine the functional status of acute and chronic lower extremity musculoskeletal dysfunction. It is a 20-item questionnaire whose items are ranged in a five-point scale ranging from zero to four to assess the difficulty in performing different tasks due to physical dysfunction in the lower extremities. The final score of all the items is calculated on a 0-80 score scale, correlated with low and high functional levels respectively, and has been deemed to be a valid and reliable self-reported assessment tool
From baseline to 8 weeks
Short Form-36 (SF-36)
Time Frame: From baseline to 8 weeks
The SF-36 is widely utilized as a comprehensive measure of health-related quality of life. It comprises 36 items categorized into eight domains: physical functioning, physical role, body pain, general health, vitality, social functioning, emotional role, and mental health. Additionally, it offers summary scores for the physical and mental components (PCS and MCS), with higher scores indicating better overall health-related quality of life.
From baseline to 8 weeks
Berg Balance Scale (BBS)
Time Frame: From baseline to 8 weeks
This assessment tool is employed for balance evaluation. It comprises 14 items, each rated from 0 to 4, with the scores aggregated to yield a total score ranging from 0 to 56. A higher total score signifies improved balance. Scores between 0 and 20 indicate wheelchair mobility, 21 to 40 suggest walking with assistance, while a score of 41 to 56 indicates independent walking ability.
From baseline to 8 weeks
Pittsburgh Sleep Quality Index
Time Frame: From baseline to 8 weeks
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire used to assess sleep quality and disturbances over a one-month time interval. It evaluates seven components of sleep, including subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction. Each component is scored on a scale of 0 to 3, with higher scores indicating poorer sleep quality. The total score, which ranges from 0 to 21, is calculated by summing the scores of the seven components, with higher scores indicating worse overall sleep quality. The PSQI is widely used in both clinical and research settings to evaluate sleep patterns and disturbances.
From baseline to 8 weeks
Brief Pain Questionnaire
Time Frame: From baseline to 8 weeks
The Brief Pain Inventory (BPI) is a widely used self-report questionnaire designed to assess the severity of pain and its impact on various aspects of daily functioning. It consists of two main sections: the Pain Severity Scale and the Pain Interference Scale. The Pain Severity Scale assesses the intensity of pain at its "worst," "least," "average," and "right now" over the past week, rated on a scale from 0 (no pain) to 10 (pain as bad as you can imagine). The Pain Interference Scale evaluates the degree to which pain interferes with various domains of daily life, such as general activity, mood, walking ability, normal work, relations with others, sleep, and enjoyment of life. Responses are also rated on a scale from 0 (does not interfere) to 10 (completely interferes).
From baseline to 8 weeks
Perceived Stress Scale
Time Frame: From baseline to 8 weeks
The Perceived Stress Scale (PSS) is a self-report questionnaire designed to measure the perception of stress in individuals over the past month. It consists of 10 items that assess the degree to which situations in one's life are appraised as stressful. Respondents rate the frequency of their feelings and thoughts related to stress on a scale from 0 (never) to 4 (very often). The items cover various aspects of stress, including feelings of unpredictability, lack of control, and overwhelm. The scores for each item are summed to obtain a total score, with higher scores indicating higher levels of perceived stress.
From baseline to 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: David Cruz Diaz, PhD, University of Jaén

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2023

Primary Completion (Actual)

November 14, 2023

Study Completion (Actual)

November 20, 2023

Study Registration Dates

First Submitted

February 14, 2024

First Submitted That Met QC Criteria

February 14, 2024

First Posted (Actual)

February 22, 2024

Study Record Updates

Last Update Posted (Actual)

February 23, 2024

Last Update Submitted That Met QC Criteria

February 22, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on Conventional physiotherapy

Subscribe